(Q42989881)

12 November 2017

title

MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course (English)

1 reference

12 November 2017

main subject

liver transplantation

1 reference

1 reference

7

1 reference

12 November 2017

8

Peter Neuhaus

1 reference

12 November 2017

1

Marcus Bahra

1 reference

12 November 2017

4

Gero Puhl

1 reference

12 November 2017

U I F P Neumann

2

1 reference

12 November 2017

Dietmar Jacob

series ordinal

3

1 reference

12 November 2017

Jochen Klupp

series ordinal

5

1 reference

12 November 2017

Jan M Langrehr

series ordinal

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

American Journal of Transplantation

12 November 2017

published in

1 reference

12 November 2017

volume

5

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

406-411

1 reference

Long-term outcome of hepatitis C infection after liver transplantation

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Indications for mycofenolate mofetil therapy after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Impact of immunosuppressive therapy on recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

New therapeutic strategies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

Immunosuppressive strategies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00706.X

10.1111/J.1600-6143.2004.00706.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference